[{"NetIncomeLossConverted_1_Q2_USD":-33535000.0,"NetIncomeLossConverted_2_Q2_USD":-64938000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":-62683000.0,"CommonStockSharesOutstanding_0_Q2_shares":128233842.0,"StockholdersEquity_0_Q2_USD":529939000.0,"EarningsPerShareBasic_2_Q2_USD":-0.51,"EarningsPerShareBasic_1_Q2_USD":-0.26,"RevenuesConverted_1_Q2_USD":20988000.0,"RevenuesConverted_2_Q2_USD":41898000.0,"Assets_0_Q2_USD":854822000.0,"CommonStockSharesConverted_0_Q2_shares":128233842.0,"Ticker":"ADPT","CIK":"1478320","name":"ADAPTIVE BIOTECHNOLOGIES CORP","OfficialName":"Adaptive Biotechnologies Corporation Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1463975665.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]